The test boast of rapid and accurate diagnosis with the following characteristics:
Clinical Performance For IgM Test
34 specimens from fresh infected patients mixed with 300
specimens derived from non-infected individuals were tested
by the Leishmania IgG/IgM Ab Combo Rapid Test.
Relative Sensitivity: 91%, Relative Specificity: 99.6%, Overall Agreement: 98.5%
|Product name||Leishmania IgG/IgM Ab Combo Rapid Test|
|Place of Origin||Beijing, China|
|After-sale Service||Online technical support|
|Shelf Life||2 years|
|Quality Certification||ISO9001, ISO13485|
|Instrument classification||Class II|
|Specimen||human whole blood, serum or plasma..|
|Package||1pc/box, 25pcs/box, 50 pcs/box, 100pcs/box, customized|
Packaging: 1pc/box; 25pcs/box, 50 pcs/box, 100pcs/box, individual aluminium foil bag package for each piece product; OEM packing is available.
Port: any ports of China, optional.
Beijing Jinwofu Bioengineering Technology Co., Ltd. focuses on high-quality in vitro diagnostic reagents. Through independent research and development, it has formed the core products of rapid in vitro diagnostic reagents with independent intellectual property rights: colloidal gold, latex rapid immune diagnostic reagent products, such as infectious disease detection series, eugenics and eugenics detection series, infectious disease detection products, etc.
Welcome to contact us for more information!